Zhenhua Hu Selected Research

Neoplasms (Cancer)

11/2022	PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe.
1/2022	Optimization of ODAP-Urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging.
1/2022	First Clinical Investigation of Near-Infrared Window IIa/IIb Fluorescence Imaging for Precise Surgical Resection of Gliomas.
1/2022	Case Report: The Second Near-Infrared Window Indocyanine Green Angiography in Giant Mediastinal Tumor Resection.
10/2021	Visualizing Tumors in Real Time: A Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection.
7/2021	Radiopharmaceutical and Eu3+ doped gadolinium oxide nanoparticles mediated triple-excited fluorescence imaging and image-guided surgery.
2/2021	Feasibility of pancreaticoduodenectomy with synchronous liver metastasectomy for oligometastatic pancreatic ductal adenocarcinoma - A case-control study.
1/2021	A narrative review of near-infrared fluorescence imaging in hepatectomy for hepatocellular carcinoma.
10/2020	MicroRNA-572/hMOF/Sirt6 regulates the progression of ovarian cancer.
10/2020	A preliminary study of dual-band confocal laser endomicroscopy combined with image mosaic in the diagnosis of liver cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenhua Hu Research Topics

Disease

44	Neoplasms (Cancer) 11/2022 - 09/2008
23	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 10/2012
16	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2012
15	Ovarian Epithelial Carcinoma 08/2017 - 11/2012
7	Neoplasm Metastasis (Metastasis) 02/2021 - 11/2012
5	Carcinoma (Carcinomatosis) 02/2015 - 10/2012
4	End Stage Liver Disease 04/2017 - 01/2013
3	Glioma (Gliomas) 01/2022 - 05/2010
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
3	Liver Neoplasms (Liver Cancer) 01/2021 - 11/2013
3	Diabetes Mellitus 01/2020 - 01/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017 - 09/2008
3	Residual Neoplasm 07/2017 - 11/2012
2	Stomach Neoplasms (Stomach Cancer) 03/2022 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2021
2	Adenocarcinoma 02/2021 - 01/2018
2	Lymphatic Metastasis 07/2017 - 11/2014
2	Hepatitis C 12/2014 - 01/2013
2	Hepatitis B 01/2014 - 01/2013
2	Infections 01/2014 - 01/2008
1	Glioblastoma (Glioblastoma Multiforme) 11/2022
1	Signet Ring Cell Carcinoma 03/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Cysts 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Nasopharyngeal Carcinoma 08/2021
1	Leukemia 01/2021
1	Primary Hyperoxaluria (Oxaluria, Primary) 07/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 09/2016 - 09/2008
13	Lewis Y antigenIBA 12/2017 - 11/2012
8	Pharmaceutical PreparationsIBA 01/2020 - 11/2012
6	AntigensIBA 01/2022 - 01/2013
5	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 10/2020
5	Messenger RNA (mRNA)IBA 01/2021 - 09/2008
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2010
4	RadiopharmaceuticalsIBA 07/2021 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 05/2010
4	Biological ProductsIBA 04/2016 - 05/2010
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2015
3	MicroRNAs (MicroRNA)IBA 10/2020 - 10/2012
3	Gemcitabine FDA Link 01/2019 - 11/2016
2	Fluorescein (Funduscein)FDA LinkGeneric 10/2020 - 07/2019
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2017 - 12/2012
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2017 - 05/2012
2	ParaffinIBA 09/2016 - 01/2015
2	Annexin A2 (Annexin II)IBA 04/2015 - 11/2014
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2014 - 01/2013
2	Beclin-1IBA 03/2014 - 12/2012
2	IntegrinsIBA 06/2013 - 11/2012
2	Small Interfering RNA (siRNA)IBA 12/2012 - 10/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2022
1	Sulfides (Thioethers)IBA 01/2022
1	oxalyldiaminopropionic acidIBA 01/2022
1	Radioisotopes (Radionuclides)IBA 01/2022
1	AngiomotinsIBA 01/2022
1	IndiumIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	CopperIBA 01/2022
1	Hepatocyte Nuclear FactorsIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	PolymersIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2021
1	Polyvinyl AlcoholIBA 07/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021
1	LigandsIBA 01/2021
1	Laminin (Merosin)IBA 01/2021
1	Coloring Agents (Dyes)IBA 10/2020
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 10/2020
1	EnzymesIBA 07/2020
1	Oxalic Acid (Disodium Oxalate)IBA 07/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Autophagy-Related ProteinsIBA 01/2020
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2020
1	CrizotinibIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	NucleotidesIBA 01/2020

Therapy/Procedure

15	Liver Transplantation 01/2019 - 01/2008
14	Therapeutics 02/2021 - 01/2008
12	Drug Therapy (Chemotherapy) 03/2022 - 10/2012
8	Computer-Assisted Surgery (Image Guided Surgery) 11/2022 - 01/2015
3	Hepatectomy 01/2021 - 02/2015
3	Transplantation 06/2016 - 01/2014
2	Injections 01/2022 - 04/2016
2	Pancreaticoduodenectomy 02/2021 - 10/2017
2	Lasers (Laser) 10/2020 - 07/2019
1	Prostatectomy (Retropubic Prostatectomy) 10/2021
1	Induction Chemotherapy 08/2021
1	Chemoradiotherapy 08/2021
1	Metastasectomy 02/2021
1	Laparotomy 02/2021
1	Kidney Transplantation 07/2020
1	Subcutaneous Injections 01/2020